Inmune Bio (INMB) Net Equity Issued and Repurchased (2018 - 2025)

Inmune Bio (INMB) posted Net Equity Issued and Repurchased of $18.9 million for Q2 2025, up 258.43% sequentially from $5.3 million in Q1 2025.

Inmune Bio (INMB) Net Equity Issued and Repurchased (2018 - 2025) Analysis & Trends

Inmune Bio has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $18.9 million in Q2 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $18.9 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (changed N/A YoY) and the FY2025 annual result came in at $27.5 million, down 0.88% from the prior year.
Net Equity Issued and Repurchased grew to $18.9 million in Q2 2025 per INMB's latest filing, from $5.3 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $51.8 million in Q3 2021 and troughed at $5.3 million in Q1 2025.
A 3-year average of $23.5 million and a median of $18.9 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
The widest YoY moves for Net Equity Issued and Repurchased: up 2736.09% in 2021, down 122.92% in 2021.
Over 3 years, Net Equity Issued and Repurchased stood at $51.8 million in 2021, then tumbled by 74.91% to $13.0 million in 2024, then surged by 45.38% to $18.9 million in 2025.
According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $18.9 million, $5.3 million, and $13.0 million for Q2 2025, Q1 2025, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Inmune Bio	61.59 Mn	43.18 Mn	-	-

Download Data